Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma

被引:102
作者
Steinke, K
King, J
Glenn, D
Morris, DL
机构
[1] St George Hosp, Kogarah, NSW 2217, Australia
[2] Univ New S Wales, Dept Surg, Sydney, NSW, Australia
[3] Univ New S Wales, Dept Radiol, Sydney, NSW, Australia
关键词
minimally invasive; radiofrequency ablation; lung; computed tomography; morphology; complications;
D O I
10.1097/00004728-200309000-00012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Objectives: To describe the morphologic appearance over time of percutaneously radiofrequency-ablated pulmonary metastases from colorectal cancer and to focus on the occurrence of the most common complications. Methods: Twenty patients have been treated with computed tomography (CT)-guided radiofrequency ablation (RFA) for 41 pulmonary metastases using the expandable 14-gauge StarBurst XL RF electrode along with the 1500 generator (RITA Medical Systems, Mountain View, CA). The average number of lesions per patient was 2.05, ranging from I to 4 lesions. Results: The typical feature of the radiofrequency-ablated site immediately after the procedure was a light bulb-shaped opacification surrounding the probe. This became a more spherically shaped feature over time and steadily decreased in size. At 3 months after RFA, the lesion was approximately the same size as at baseline. The lesion subsequently shrank within the following 3 months, usually with a small scar remaining. Pneumothorax occurred in 50% of the patients, and a chest tube was required in 50% of the patients affected. Cavitation occurred in 24% of the lesions. Intraparenchymal hemorrhage was observed in 7.5% of the cases. Conclusions: Image-guided pulmonary RFA is a safe minimally invasive therapy modality with acceptable morbidity. Ablated lesion size usually exceeds the dimensions of the initial tumor for the first 3 months after ablation and continuously shrinks thereafter.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 32 条
[1]
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation [J].
Anderson, GS ;
Brinkmann, F ;
Soulen, MC ;
Alavi, A ;
Zhuang, HM .
CLINICAL NUCLEAR MEDICINE, 2003, 28 (03) :192-197
[2]
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases [J].
Berber, E ;
Flesher, N ;
Siperstein, AE .
WORLD JOURNAL OF SURGERY, 2002, 26 (08) :985-990
[3]
Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned [J].
Bleicher, RJ ;
Allegra, DP ;
Nora, DT ;
Wood, TF ;
Foshag, LJ ;
Bilchik, AJ .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) :52-58
[4]
Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors [J].
Bowles, BJ ;
Machi, J ;
Limm, WML ;
Severino, R ;
Oishi, AJ ;
Furumoto, NL ;
Wong, LL ;
Oishi, RH .
ARCHIVES OF SURGERY, 2001, 136 (08) :864-868
[5]
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies - Results in 123 patients [J].
Curley, SA ;
Izzo, F ;
Delrio, P ;
Ellis, LM ;
Granchi, J ;
Vallone, P ;
Fiore, F ;
Pignata, S ;
Daniele, B ;
Cremona, F .
ANNALS OF SURGERY, 1999, 230 (01) :1-8
[6]
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis [J].
Curley, SA ;
Izzo, F ;
Ellis, LM ;
Vauthey, JN ;
Vallone, P .
ANNALS OF SURGERY, 2000, 232 (03) :381-389
[7]
Percutaneous radiofrequency ablation of malignancies in the lung [J].
Dupuy, DE ;
Zagoria, RJ ;
Akerley, W ;
Mayo-Smith, WW ;
Kavanagh, PV ;
Safran, H .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (01) :57-59
[8]
Clinical applications of radio-frequency tumor ablation in the thorax [J].
Dupuy, DE ;
Mayo-Smith, WW ;
Abbott, GF ;
DiPetrillo, T .
RADIOGRAPHICS, 2002, 22 :S259-S269
[9]
Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy [J].
Dupuy, DE ;
Monchik, JM ;
Decrea, C ;
Pisharodi, L .
SURGERY, 2001, 130 (06) :971-977
[10]
Friedel G, 1999, ZBL CHIR, V124, P96